These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25415815)

  • 1. Echocardiographic assessment of systolic pulmonary arterial pressure in HIV-positive patients.
    Rasoulinejad M; Moradmand Badie S; Salehi MR; Seyed Alinaghi SA; Dehghan Manshadi SA; Zakerzadeh N; Foroughi M; Jahanjo Amin Abad F; Moradmand Badie B
    Acta Med Iran; 2014; 52(11):827-30. PubMed ID: 25415815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications.
    Badie SM; Rasoulinejad M; Salehi MR; Kochak HE; Alinaghi SAS; Manshadi SAD; Abad FJA; Badie BM
    Infect Disord Drug Targets; 2017; 17(1):43-51. PubMed ID: 27919209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study.
    Reinsch N; Buhr C; Krings P; Kaelsch H; Kahlert P; Konorza T; Neumann T; Erbel R;
    HIV Med; 2008 Aug; 9(7):550-6. PubMed ID: 18557952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary hypertension in human immunodeficiency virus-infected patients: the role of antiretroviral therapy].
    Olalla J; Urdiales D; Pombo M; del Arco A; de la Torre J; Prada JL
    Med Clin (Barc); 2014 Mar; 142(6):248-52. PubMed ID: 23490486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-Related pulmonary hypertension: analytic review of 131 cases.
    Mehta NJ; Khan IA; Mehta RN; Sepkowitz DA
    Chest; 2000 Oct; 118(4):1133-41. PubMed ID: 11035689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.
    Hachulla E; Clerson P; Airò P; Cuomo G; Allanore Y; Caramaschi P; Rosato E; Carreira PE; Riccieri V; Sarraco M; Denton CP; Riemekasten G; Pozzi MR; Zeni S; Mihai CM; Ullman S; Distler O; Rednic S; Smith V; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Launay D;
    Rheumatology (Oxford); 2015 Jul; 54(7):1262-9. PubMed ID: 25596413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise echocardiography for the assessment of pulmonary hypertension in systemic sclerosis: a systematic review.
    Baptista R; Serra S; Martins R; Teixeira R; Castro G; Salvador MJ; Pereira da Silva JA; Santos L; Monteiro P; Pêgo M
    Arthritis Res Ther; 2016 Jul; 18(1):153. PubMed ID: 27368695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of pulmonary arterial hypertension in a cohort of asymptomatic HIV-infected patients.
    Isasti G; Moreno T; Pérez I; Cabrera F; Palacios R; Santos J
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):231-4. PubMed ID: 22849654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran.
    Koochak HE; Babaii A; Pourdast A; Golrokhy R; Rasoolinejad M; Khodaei S; Moghadam SRJ; Taheri RR; Seyed Alinaghi SA
    Infect Disord Drug Targets; 2017; 17(2):116-119. PubMed ID: 28164754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic abnormalities and associated factors in a cohort of asymptomatic HIV-infected patients.
    Isasti G; Pérez I; Moreno T; Cabrera F; Palacios R; Santos J
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):20-4. PubMed ID: 22891715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in HIV infection: a prospective echocardiographic study.
    Schwarze-Zander C; Pabst S; Hammerstingl C; Ohlig J; Wasmuth JC; Boesecke C; Stoffel-Wagner B; Carstensen A; Nickenig G; Strassburg CP; Rockstroh JK; Skowasch D; Schueler R
    HIV Med; 2015 Oct; 16(9):578-82. PubMed ID: 25960172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
    Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
    Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 2-dimensional Doppler echo-cardiography in screening portopulmonary hypertension in portal hypertension patients.
    Hua R; Sun YW; Wu ZY; Cheng W; Xu Q; Cao H; Luo M
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):157-61. PubMed ID: 19357029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.
    Bergersen BM
    Drugs; 2006; 66(15):1971-87. PubMed ID: 17100407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era.
    Sitbon O; Lascoux-Combe C; Delfraissy JF; Yeni PG; Raffi F; De Zuttere D; Gressin V; Clerson P; Sereni D; Simonneau G
    Am J Respir Crit Care Med; 2008 Jan; 177(1):108-13. PubMed ID: 17932378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy.
    Zuber JP; Calmy A; Evison JM; Hasse B; Schiffer V; Wagels T; Nuesch R; Magenta L; Ledergerber B; Jenni R; Speich R; Opravil M;
    Clin Infect Dis; 2004 Apr; 38(8):1178-85. PubMed ID: 15095226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with congenital atrial septal defects: effect of age at repair and defect size on pulmonary artery pressures prior to repair.
    Motiwala A; Fatimi SH; Akhtar N; Perveen S; Khan MZ; Atiq M
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):281-6. PubMed ID: 21412709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
    Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
    AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.